ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Milano, Lombardia

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Chronic Myelomonocytic Leukemia
Hematologic Cancer

Acute Myeloid Leukemia (AML) trials near Milano, Lombardia, ITA:

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

The purpose of this study is to learn more about the safety and efficacy of ivosidenib taken with azacitidine to treat adult patients with acute...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: Ivosidenib 500mg Oral Tablet
Drug: Azacitidine

Phase 3

Servier
Servier

Brescia, Brescia, Italy and 14 other locations

The purpose of this study is to determine the recommended Phase 2 dose (RP2D) candidate(s) of bleximenib in combination with AML directed th...

Enrolling
Leukemia, Myeloid, Acute
Drug: Cytarabine
Drug: Bleximenib

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Milan, Italy and 33 other locations

or young adults with a certain kind of blood cancer (FLT3-ITD AML) might be able to join this study if it has come back after remission or i...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Quizartinib
Drug: Cytarabine

Phase 1, Phase 2

Daiichi Sankyo
Daiichi Sankyo

Monza, Italy and 26 other locations

\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Fludarabine

Phase 3

PedAL BCU, LLC

Monza, Monza and Brianza, Italy and 85 other locations

This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Milan, Milano, Italy and 160 other locations

Older patients with acute myeloid leukemia (AML) have a small (\< 10%) chance of long-term survival. Despite the ...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: standard combination chemotherapy
Drug: decitabine

Phase 3

European Organisation for Research and Treatment of Cancer (EORTC)

Novara, Italy and 52 other locations

when administered to adult patients with relapsed or refractory acute myeloid leukemia (AML) or relapsed or progr...

Active, not recruiting
Acute Myeloid Leukemia (AML)
High-risk Myelodysplastic Syndrome
Drug: RVU120

Phase 2

Ryvu Therapeutics

Milan, Italy and 40 other locations

VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Milan, Italy and 180 other locations

chemotherapy with low intensity therapies in 1st or 2nd relapse Acute Myeloid Leukemia. The study is funded by European Co...

Enrolling
Acute Myeloid Leukemia
Relapse/Recurrence
Drug: High intensity therapies
Drug: Low intensity therapies

Phase 3

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Milan, Italy and 33 other locations

participants with AML.The duration of this multi-phase study is approximately 7 years....

Enrolling
Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Drug: Venetoclax
Drug: ASTX030 (cedazuridine + azacitidine)

Phase 2, Phase 3

Taiho Pharma
Taiho Pharma

Milan, Italy and 71 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems